Delivery Order SPE2DB20D7061-SPE2DB25FSMH4

Award Date 2/26/25
Potential Completion Date 2/27/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,172.43, is for the delivery of PHENOBARBITAL 130 MG/ML VIALML to support federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, valued at $999,999,999 and running through November 2026. This IDC...
This is a federal contract award (SPE2DX15D3006|SPE2DX25F01WP) issued by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,190.18 firm fixed-price delivery order is for the supply of 4567090412 - PHENOBARBITAL 130 MG/ML VIALML, with a performance period ending on January 30, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a larger...
This federal contract award is for the delivery of PHENOBARBITAL 130 MG/ML VIALML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including the DoD and Department of Veterans Affairs (VA) healthcare systems. The contract is a Delivery Order valued at $3,733.23, with a firm...
This federal contract award, valued at $2,320.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Phenobarbital 130 mg/ml vials, a medication used for various medical conditions. The contract does not have a set-aside designation, indicating it was open to general competition. It is a Firm Fixed Price Delivery Order with an ultimate completion date of April 19, 2023. Amerisourcebergen also...
This federal contract award, valued at $1,551.55, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of Phenobarbital 130 mg/ml vials, a medication commonly used in the treatment of seizure disorders. The contract has an ultimate completion date of March 6, 2024 and is a Firm Fixed Price arrangement. Amerisourcebergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4560011896 - Phenobarbital 65 mg/ml vial. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $1,305.61 and a completion date of February 22, 2023. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through...
This federal contract award is for the delivery of PHENOBARBITAL 130 MG/ML VIALML to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the federal government. The contract has a ceiling value of $3,381.83 and is a firm fixed-price delivery order type with a completion date of June 18, 2024....
This federal contract award is for the delivery of PHENOBARBITAL 65 MG/ML VIALML to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., as a delivery order under a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that runs through November 2026. The contract has a ceiling value of $1,124.80 and a completion date of January 24, 2024. This contract is not designated as a set-aside...
This federal contract award is for the delivery of PHENOBARBITAL 65 MG/ML VIALML to the U.S. Department of Defense (DoD) and its agencies. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, and has a ceiling value of $1,223.55. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the Defense Logistics Agency (DLA) Troop Support Medical. This single-award...
This federal contract award, valued at $5,169.70, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Phenobarbital 130 mg/ml vials, a critical medication, to support military treatment facilities and other federal healthcare providers. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical,...
  • SPE2DB20D7061
    Indefinite Delivery Contract
  • SPE2DB20D7061-SPE2DB25FSMH4
    Delivery Order

This federal contract award, identified as SPE2DB20D7061|SPE2DB25FSMH4, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $1,095.09, is a Delivery Order for the supply of PHENOBARBITAL 130 MG/ML VIALML.

The contract does not have a set-aside designation, indicating it was awarded through open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as the primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Additionally, the company maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs.

Generated 5/28/25, 11:00 AM